Ayaka Okamoto

527 total citations
21 papers, 422 citations indexed

About

Ayaka Okamoto is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Ayaka Okamoto has authored 21 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Cancer Research and 3 papers in Surgery. Recurrent topics in Ayaka Okamoto's work include RNA Interference and Gene Delivery (9 papers), Advanced biosensing and bioanalysis techniques (8 papers) and MicroRNA in disease regulation (5 papers). Ayaka Okamoto is often cited by papers focused on RNA Interference and Gene Delivery (9 papers), Advanced biosensing and bioanalysis techniques (8 papers) and MicroRNA in disease regulation (5 papers). Ayaka Okamoto collaborates with scholars based in Japan, United States and China. Ayaka Okamoto's co-authors include Tomohiro Asai, Naoto Oku, Takehisa Dewa, Hiroyuki Koide, Hidenori Ando, Tetsuo Minamino, Kosuke Shimizu, Mamoru Nango, Noriyuki Maeda and Kenji Hyodo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Ayaka Okamoto

20 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ayaka Okamoto Japan 14 300 89 87 56 34 21 422
Zhuang zhuang China 9 164 0.5× 17 0.2× 63 0.7× 41 0.7× 28 0.8× 69 354
Jialiang Sun China 11 259 0.9× 63 0.7× 33 0.4× 20 0.4× 25 0.7× 25 381
Miroslava Sedláčková Czechia 11 329 1.1× 18 0.2× 31 0.4× 72 1.3× 56 1.6× 18 495
Neelesh Soman United States 9 236 0.8× 46 0.5× 79 0.9× 69 1.2× 79 2.3× 12 570
Zhaoyu Sun United States 12 285 0.9× 39 0.4× 37 0.4× 78 1.4× 28 0.8× 17 680
Edina Wang Australia 8 270 0.9× 39 0.4× 44 0.5× 46 0.8× 45 1.3× 14 453
Xiaoning Song China 9 201 0.7× 55 0.6× 89 1.0× 75 1.3× 7 0.2× 15 486

Countries citing papers authored by Ayaka Okamoto

Since Specialization
Citations

This map shows the geographic impact of Ayaka Okamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayaka Okamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayaka Okamoto more than expected).

Fields of papers citing papers by Ayaka Okamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayaka Okamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayaka Okamoto. The network helps show where Ayaka Okamoto may publish in the future.

Co-authorship network of co-authors of Ayaka Okamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Ayaka Okamoto. A scholar is included among the top collaborators of Ayaka Okamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayaka Okamoto. Ayaka Okamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakane, Keita, Ayaka Okamoto, Hiroki Kato, et al.. (2025). Significance of split-dose cisplatin-based neoadjuvant chemotherapy followed by robotic-assisted radical cystectomy for muscle invasive bladder cancer. Translational Andrology and Urology. 14(3). 589–601.
2.
Hirano, Tomoko, Ayaka Okamoto, Yoshihisa Oda, et al.. (2023). Ab-GALFA, A bioassay for insect gall formation using the model plant Arabidopsis thaliana. Scientific Reports. 13(1). 2554–2554. 5 indexed citations
3.
Asai, Tomohiro, Hiroyuki Koide, Ayaka Okamoto, et al.. (2023). Treatment of PTEN-Null Breast Cancer by a Synthetic Lethal Approach Involving PARP1 Gene Silencing. Journal of Pharmaceutical Sciences. 112(7). 1908–1914. 2 indexed citations
4.
Kamachi, Hiroyuki, et al.. (2022). Lead and Cadmium Tolerance and Accumulation of Proanthocyanidin-Deficient mutants of the Fern Athyrium yokoscense. SHILAP Revista de lepidopterología. 12(1). 9330–9330. 1 indexed citations
5.
6.
Fujiwara‐Tani, Rina, Ayaka Okamoto, Hitoshi Ohmori, et al.. (2021). BRAF Mutation Is Associated with Hyperplastic Polyp-Associated Gastric Cancer. International Journal of Molecular Sciences. 22(23). 12724–12724. 5 indexed citations
7.
Hirano, Tomoko, Seisuke Kimura, Tomoaki Sakamoto, et al.. (2020). Reprogramming of the Developmental Program of Rhus javanica During Initial Stage of Gall Induction by Schlechtendalia chinensis. Frontiers in Plant Science. 11. 471–471. 33 indexed citations
8.
Niwa, Toshiro, et al.. (2020). Comparison of steroid hormone hydroxylation mediated by cytochrome P450 3A subfamilies. Archives of Biochemistry and Biophysics. 682. 108283–108283. 20 indexed citations
9.
Zang, Liqing, Yasuhito Shimada, Hiroko Nakayama, et al.. (2019). Therapeutic Silencing of Centromere Protein X Ameliorates Hyperglycemia in Zebrafish and Mouse Models of Type 2 Diabetes Mellitus. Frontiers in Genetics. 10. 693–693. 5 indexed citations
10.
Okamoto, Ayaka, et al.. (2019). Key determinants of siRNA delivery mediated by unique pH-responsive lipid-based liposomes. International Journal of Pharmaceutics. 569. 118606–118606. 13 indexed citations
11.
Niwa, Toshiro, et al.. (2019). Comparison of Steroid Hormone Hydroxylations by and Docking to Human Cytochromes P450 3A4 and 3A5. Journal of Pharmacy & Pharmaceutical Sciences. 22(1). 332–339. 18 indexed citations
12.
Okamoto, Ayaka, Hiroyuki Koide, Naoki Morita, et al.. (2018). Rigorous control of vesicle-forming lipid pKa by fluorine-conjugated bioisosteres for gene-silencing with siRNA. Journal of Controlled Release. 295. 87–92. 16 indexed citations
13.
Okamoto, Ayaka, Tomohiro Asai, Kosuke Shimizu, et al.. (2018). Systemic Administration of siRNA with Anti-HB-EGF Antibody-Modified Lipid Nanoparticles for the Treatment of Triple-Negative Breast Cancer. Molecular Pharmaceutics. 15(4). 1495–1504. 54 indexed citations
14.
Koide, Hiroyuki, Ayaka Okamoto, Hiroki Tsuchida, et al.. (2016). One-step encapsulation of siRNA between lipid-layers of multi-layer polycation liposomes by lipoplex freeze-thawing. Journal of Controlled Release. 228. 1–8. 26 indexed citations
15.
Okamoto, Ayaka, Tomohiro Asai, Hidenori Ando, et al.. (2016). Enhanced Efficacy of Doxorubicin by microRNA-499-Mediated Improvement of Tumor Blood Flow. Journal of Clinical Medicine. 5(1). 10–10. 20 indexed citations
16.
Ando, Hidenori, Tomohiro Asai, Hiroyuki Koide, et al.. (2014). Advanced cancer therapy by integrative antitumor actions via systemic administration of miR-499. Journal of Controlled Release. 181. 32–39. 36 indexed citations
17.
Okamoto, Ayaka, Tomohiro Asai, Hiroki Kato, et al.. (2014). Antibody-modified lipid nanoparticles for selective delivery of siRNA to tumors expressing membrane-anchored form of HB-EGF. Biochemical and Biophysical Research Communications. 449(4). 460–465. 36 indexed citations
18.
Asai, Tomohiro, Ayaka Okamoto, Takehisa Dewa, et al.. (2014). Cell-penetrating peptide-conjugated lipid nanoparticles for siRNA delivery. Biochemical and Biophysical Research Communications. 444(4). 599–604. 66 indexed citations
19.
Ando, Hidenori, et al.. (2013). Polycation liposomes as a vector for potential intracellular delivery of microRNA. The Journal of Gene Medicine. 15(10). 375–383. 17 indexed citations
20.
Ando, Hidenori, Ayaka Okamoto, Kosuke Shimizu, et al.. (2012). Development of a miR‐92a delivery system for anti‐angiogenesis‐based cancer therapy. The Journal of Gene Medicine. 15(1). 20–27. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhuang zhuang Breakdown of academic impact, for papers by Jialiang Sun Breakdown of academic impact, for papers by Miroslava Sedláčková Breakdown of academic impact, for papers by Neelesh Soman Breakdown of academic impact, for papers by Zhaoyu Sun Breakdown of academic impact, for papers by Edina Wang Breakdown of academic impact, for papers by Xiaoning Song
Rankless by CCL
2026